Cyclo Therapeutics Inc (CYTH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CYTH Annual Balance Sheets →
From Cyclo Therapeutics Inc through Sep 30 2023, shifts in Sep 30 2024's assets and liabilities provide insight into the company's capital structure and financial stability.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent0.93
Cash & Short-term Investments0.00
Accounts receivable0.19
Inventories0.24
Other Current Assets1.73
Prepaid Insurance PR0.18
Total Current Assets3.26
Equipment/Property/Plant Net0.02
Prepaid Expense, Noncurrent, Total PR1.95
Other Assets, Noncurrent0.00
Prepaid Expenses Current Excluding Prepaid Insurance1.73
Operating Lease Right Of Use Asset0.03
Total Assets5.25
Liabilities
Accounts Payable and Accrued Liabilities, Current LI6.52
Convertible Notes Payable, Current NO12.18
Other Liabilities, Current0.00
Total Current Liabilities18.72
Total Long-term Debt0.00
Operating Lease Liability Current0.02
Operating Lease Liability Noncurrent0.01
Total Liabilities18.73
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock89.54
Retained Earnings / Accumulated Deficit-103.01
Other Equity0.00
Common Stockholder's Equity-13.48
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-13.47
Liabilities & Stockholder's Equity5.25
4 historic quarters locked

Sign in to unlock the full Cyclo Therapeutics Inc balance sheet history.

About Cyclo Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-24-035006

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.